CoChat

Do atypical features affect outcome in depressed outpatients treated with citalopram?

Open access
Stewart, Jonathan W., McGrath, Patrick J., Fava, Maurizio, Wisniewski, Stephen R., Zisook, Sidney, Cook, Ian, Nierenberg, Andrew A., Trivedi, Madhukar H., Balasubramani, G. K., Warden, Diane, Lesser, Ira, John Rush, A. · 2010 · The International Journal of Neuropsychopharmacology
Cited by 64

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Depressed patients with atypical features have an earlier onset of depression, a more chronic course of illness, several distinctive biological and familial features, and a different treatment response than those without atypical features. The efficacy and tolerability of selective serotonin reuptake inhibitors (SSRIs) have not been fully evaluated in depression with atypical features. This report evaluates data from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study to determine whether depressed outpatients with and without atypical features respond differently to the SSRI citalopram. Treatment-seeking participants with non-psychotic major depressive disorder were recruited from primary- and psychiatric-care settings. The presence/absence of atypical features was approximated using baseline ratings on the 30-item Inventory of Depressive Symptomatology - Clinician-rated. Following baseline assessments, participants received citalopram up to 60 mg/d for up to 14 wk. Baseline sociodemographic and clinical characteristics, and treatment outcomes, were compared between participants with and without atypical features. Of the 2876 evaluable STAR*D participants, 541 (19%) had atypical features. Participants with atypical features were significantly more likely to be female, younger, unemployed, have greater physical impairment, a younger age of depression onset, a longer index episode, greater depressive severity, and more concurrent anxiety diagnoses. Those with atypical features had significantly lower remission rates, although this difference was no longer present after adjustment for baseline differences. Depressed patients with atypical features are less likely to remit with citalopram than those without atypical features. This finding is probably due to differences in baseline characteristics other than atypical symptom features.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s1461145709000182

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 64

Metadata

Authors
Stewart, J. W., McGrath, P. J., Fava, M., Wisniewski, S. R., Zisook, S., Cook, I., Nierenberg, A. A., Trivedi, M. H., Balasubramani, G. K., Warden, D., Lesser, I., & John Rush, A.
Venue
The International Journal of Neuropsychopharmacology
Published
2009-04-03
Volume
13
Issue
01
Pages
15
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2159275391
Cited by
64
References
14
FWCI
2.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Do atypical features affect outcome in depressed outpatients treated with citalopram? https://app.cochat.ai/papers/10.1017/s1461145709000182
The paper
Stewart, J. W., McGrath, P. J., Fava, M., Wisniewski, S. R., Zisook, S., Cook, I., Nierenberg, A. A., Trivedi, M. H., Balasubramani, G. K., Warden, D., Lesser, I., & John Rush, A. (2010). Do atypical features affect outcome in depressed outpatients treated with citalopram? The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145709000182

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.